Qlife Holding AB (publ) (STO:QLIFE)

Market Cap	64.06M +133.2%
Revenue (ttm)	235.00K +46.9%
Net Income	-20.66M
EPS	-1.64
Shares Out	31.64M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	50,804
Open	1.942
Previous Close	2.025
Day's Range	1.874 - 1.982
52-Week Range	1.205 - 5.740
Beta	0.59
Analysts	n/a
Price Target	440.00 (+22,840.56%)
Earnings Date	Aug 26, 2026

About Qlife Holding AB

Qlife Holding AB (publ), a med-tech company, manufactures and sells in-vitro diagnostic analyzers and reagents in Sweden. The company offers Egoo.Health Platform, a product platform that enables advanced biomarker testing, consisting of a small device, disposable capsules, and the supplementing software. Qlife Holding AB (publ) was incorporated in 2019 and is based in Gothenburg, Sweden.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2019
• Employees: 4
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: QLIFE

Financial Performance

In 2025, Qlife Holding AB's revenue was 324,000, an increase of 548.00% compared to the previous year's 50,000. Losses were -20.56 million, -63.24% less than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jun 15, 2026

Data Sources Report a data error